Dispersive-cohesive OVD performs well during all stages of lens removal

Article

One surgeon's preference for an ophthalmic viscosurgical device of 1.6% sodium hyaluronate was reinforced by a study that found it superior to another OVD during phaco and OVD removal

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Subscribe Now!
Recent Videos
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
Abdelrahman Elhusseiny, MD, MSc, discusses his AAO presentation on risk of posterior capsular rupture in fellow-eyes cataract surgery
Dr Rick Lewis discusses the FLigHT procedure and ViaLase laser at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
Marjorie Rah, OD, PhD, FAAO
Josefina Botta, MD, MSc, at ASCRS 2024
Related Content
A person's hands are visible as they search in a file cabinet. Concept image for new categorisation of intraocular lens. Image credit: ©Stephen Coburn – stock.adobe.com

How a newly defined category of IOLs can benefit patient outcomes

Joaquín Fernández Pérez, MD, PhD, MSc
June 30th 2025
Article

A new functional classification can help achieve precise vision goals

From left, clockwise: scans of a patient's left and right eyes; a photo of article author Johann Krüger, MD; Dr Krüger's handwritten notes from a custom match IOL implantation

Custom matching IOLs is key to managing patient satisfaction

Johann Krüger, MD
June 26th 2025
Article

Johann Krüger, MD, shares insights from 26 years of experience

A map or globe, with Europe emphasised under a magnifying glass. Concept image for European launch of Johnson and Johnson presbyopia-correcting Tecnis Odyssey IOL. Image credit: ©Pakawadee – stock.adobe.com

Johnson & Johnson launches presbyopia-correcting Tecnis Odyssey IOL in Europe

Martin David Harp
June 17th 2025
Article

The Tecnis Odyssey, launched in the US in October 2024, is now available in Europe, the Middle East and Canada

An image of two medical professionals in medical scrubs standing and talking in a medical facility. Concept image for surgery, consultant and resident ophthalmologists, immediate sequential bilateral cataract surgery, outcomes for ISBCS and eye care. Image credit: ©Rawpixel.com – stock.adobe.com

Resident and consultant ophthalmologists compare immediate sequential bilateral cataract surgery successes

Lynda Charters
June 12th 2025
Article

A new study compared results to determine a more comprehensive understanding of the relationship between the grade of surgeon and ISBCS outcomes

The European Commission building in Brussels, Belgium, with EU flags on view out front. Concept image for EC pharmaceutical ophthalmic drug approval. Image credit: ©xbrchx – stock.adobe.com

European Commission approves low-dose atropine eye drop Ryjunea, Santen announces

Hattie Hayes
June 5th 2025
Article

The 0.1 mg/ml atropine eye drop for paediatric myopia is licensed from Sydnexis, Inc.

Prof Alió is a member of the Ophthalmology Times Europe Editorial Advisory Board. Here, he holds the certificate of his International Research Excellence Award. Image courtesy of Prof Jorge Alió

Jorge Alió, MD, PhD, FEBOphth, FWCRS, receives 2024 International Research Excellence Award

Hattie Hayes
May 23rd 2025
Article

Prof Alió was commended for his work in microincisional cataract surgery and accommodative IOLs for presbyopia

© 2025 MJH Life Sciences

All rights reserved.